Delivery Order SPE2DB22D9143-SPE2DB25FZA86
Award Date
10/31/24
Potential Completion Date
11/1/24
Potential Value
$137K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Trikafta, a specialized pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $38,633.14 and a performance period ending on February 21, 2025. DMS Pharmaceutical Group Inc. holds a larger Indefinite...
This federal contract award is for the delivery of Trikafta 100-50-75 mg/75 mg pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense (DoD). The $18,526.83 firm fixed-price delivery order was awarded on August 5, 2024 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois, with a performance completion date of August 6, 2024. DMS Pharmaceutical Group has an existing indefinite delivery contract...
The federal contract award is for the delivery of Trikafta, a specialized pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract, valued at $18,488.12, is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract does not have a set-aside designation. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain,...
This contract award is for the pharmaceutical product Trikafta, which is being provided to the Defense Logistics Agency (DLA) by DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is a firm fixed-price delivery order under a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA. The IDC enables the DLA to issue delivery orders for a comprehensive range of pharmaceutical...
This federal contract award is for delivery orders of the pharmaceutical product Trikafta 100-50-75 mg/150 mg under a firm fixed-price contract with the Defense Logistics Agency (DLA), a defense agency within the Department of Defense (DoD). The contract has a ceiling value of $36,637.50 and an ultimate completion date of September 12, 2023. The prime contractor is DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. DMS...
This contract award, SPE2DB20D9127|SPE2DB23FPQC1, is for the delivery of Trikafta, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The $54,984.87 firm fixed-price delivery order was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $18,526.83 to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical product Trikafta. The contract has a firm fixed price and an ultimate completion date of May 8, 2024. DMS Pharmaceutical Group Inc. is a prime vendor for the DLA's Medical Supply Chain program, which provides pharmaceutical and medical supplies to the Department of Defense (DoD) and Department of Veterans...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $18,526.83 firm fixed-price delivery order is for the specialized medication Trikafta, with an ultimate completion date of October 17, 2024. The contract is not associated with a set-aside designation. DMS Pharmaceutical Group Inc. holds a single-award Indefinite Delivery Contract (IDC) worth...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order, valued at $18,526.83, is for the delivery of Trikafta, a branded pharmaceutical product, with a period of performance through May 14, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, that runs through December 31, 2025....
This federal contract award is for a delivery order valued at $74,107.32, issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the procurement of Trikafta, a specialized pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This IDC...